Abilify and Scleroma - a phase IV clinical study of FDA data

Summary:

Scleroma is reported as a side effect among people who take Abilify (aripiprazole), especially for people who are female, 50-59 old, also take Vitamin D, and have Neuroendocrine tumor.

The phase IV clinical study analyzes which people have Scleroma when taking Abilify. It is created by eHealthMe based on reports of 97,308 people who have side effects when taking Abilify from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

What is Scleroma?

Scleroma (a hardened patch of tissue in the skin or mucous membranes) is found to be associated with 308 drugs and 490 conditions by eHealthMe. Check the latest studies of Scleroma.

On Jul, 22, 2026

97,308 people reported to have side effects when taking Abilify.
Among them, 16 people (0.02%) have Scleroma.

Among these 16 people:

What is the gender of people who have Scleroma when taking Abilify? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Scleroma when taking Abilify? *

What are other drugs people take besides Abilify? *

What are other side effects people have besides Scleroma? *

Pain: 14 people, 87.50%
Fatigue (feeling of tiredness): 13 people, 81.25%
Rashes (redness): 12 people, 75.00%
Joint Pain: 12 people, 75.00%
Nausea (feeling of having an urge to vomit): 12 people, 75.00%
Oedema Peripheral (superficial swelling): 12 people, 75.00%
Bone Pain: 12 people, 75.00%
High Blood Pressure: 12 people, 75.00%
Injection Site Pain: 11 people, 68.75%
Peripheral Swelling: 11 people, 68.75%

What are the existing conditions these people have? *

Neuroendocrine Tumor: 10 people, 62.50%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 12.50%
Renal Disorder (kidney disease): 2 people, 12.50%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 12.50%
Breast Cancer: 2 people, 12.50%
Stress And Anxiety: 1 person, 6.25%
Nausea (feeling of having an urge to vomit): 1 person, 6.25%
Migraine (headache): 1 person, 6.25%
Hypersensitivity: 1 person, 6.25%
Dyspnea (difficult or laboured breathing): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and have Scleroma?

- Check whether Scleroma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abilify:

Abilify (101,454 reports)

Scleroma treatments and more:

Scleroma (2,214 reports)

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Scleroma:

Scleroma (308 drugs)

Browse all the conditions that are associated with Scleroma:

Scleroma (490 conditions)

Related publications that referenced our studies

Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.